User profiles for Ganesan Karthikeyan

Karthikeyan, G

- Karthikeyan, Ganesan - Verified email at aiims.edu - Cited by 86343

Karthikeyan Ganesan

- Verified email at amity.edu - Cited by 1038

[HTML][HTML] Acute rheumatic fever and rheumatic heart disease

…, L Guilherme, G Karthikeyan… - Nature reviews Disease …, 2016 - nature.com
Acute rheumatic fever (ARF) is the result of an autoimmune response to pharyngitis caused
by infection with group A Streptococcus. The long-term damage to cardiac valves caused by …

Is a pre-operative brain natriuretic peptide or N-terminal pro–B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes …

G Karthikeyan, RA Moncur, O Levine… - Journal of the American …, 2009 - jacc.org
Objectives : We conducted a systematic review and meta-analysis to determine if pre-operative
brain natriuretic peptide (BNP) (ie, BNP or N-terminal pro–B-type natriuretic peptide [NT-…

Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study

…, FJ He, G Howard, F Hu, L Inker, G Karthikeyan… - Journal of the American …, 2020 - jacc.org
Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are
the leading cause of global mortality and a major contributor to disability. This paper reviews …

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

…, R Jasrasaria, S Jayaraman, N Johns, G Karthikeyan… - The lancet, 2012 - thelancet.com
Background Reliable and timely information on the leading causes of death in populations,
and how these are changing, is a crucial input into health policy debates. In the Global …

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

…, E Hogeland, D Hoy, D Jarvis, JB Jonas, G Karthikeyan… - The Lancet, 2012 - thelancet.com
Background Measurement of the global burden of disease with disability-adjusted life-years
(DALYs) requires disability weights that quantify health losses for all non-fatal …

[HTML][HTML] Global, regional, and national burden of rheumatic heart disease, 1990–2015

…, SM Colquhoun, G Karthikeyan… - … England Journal of …, 2017 - Mass Medical Soc
Background Rheumatic heart disease remains an important preventable cause of
cardiovascular death and disability, particularly in low-income and middle-income countries. We …

Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY …

L Zühlke, ME Engel, G Karthikeyan… - European heart …, 2015 - academic.oup.com
Aims Rheumatic heart disease (RHD) accounts for over a million premature deaths annually;
however, there is little contemporary information on presentation, complications, and …

[HTML][HTML] Rivaroxaban in rheumatic heart disease–associated atrial fibrillation

SJ Connolly, G Karthikeyan, M Ntsekhe… - … England Journal of …, 2022 - Mass Medical Soc
Background Testing of factor Xa inhibitors for the prevention of cardiovascular events in patients
with rheumatic heart disease–associated atrial fibrillation has been limited. Methods We …

A microfluidic model for single-cell capillary obstruction by Plasmodium falciparum-infected erythrocytes

JP Shelby, J White, K Ganesan… - Proceedings of the …, 2003 - National Acad Sciences
Severe malaria by Plasmodium falciparum is a potentially fatal disease, frequently unresponsive
to even the most aggressive treatments. Host organ failure is associated with acquired …

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

…, J Pogue, D Paparella, DI Sessler, G Karthikeyan… - The Lancet, 2015 - thelancet.com
Background Cardiopulmonary bypass initiates a systemic inflammatory response syndrome
that is associated with postoperative morbidity and mortality. Steroids suppress inflammatory …